poisar

Stocks · News reference

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Chandrima Sanyal

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ARKGCRSPGHIBBIDNAMRKMRNATEMTXGXBI
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  3. Rick Munarriz

    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

    Cathie Wood's Ark Invest added to positions in Nvidia, Broadcom, and Intellia Therapeutics on Friday as these stocks declined. Nvidia exceeded earnings expectations with 106% revenue growth and raised guidance to 70% for fiscal 2028, now trading at 14x forward earnings. Broadcom is on track for accelerating growth with an upcoming earnings report. Intellia, a gene-editing biotech, has declined over 50% from recent highs but remains well-funded with analyst support.

    NVDAAVGONTLAARKG
  4. Benzinga Newsdesk

    Anthropic CEO Dario Amodei Posts On X "Today we announced the Claude-led discovery of a molecular machine that we suspect could represent a new gene editing mechanism. Its precise function, biotechnological utility (if any), or level of significance is not yet clear, but at minimum it is work I would have been proud to do as a PhD student. The work was done mostly, though not entirely, by Claude: our life sciences team suggested a broad area of research..."

    https://x.com/DarioAmodei/status/2102831170299834652

    AMZNCRSPGOOGGOOGL